Mark MacEachern

University of Michigan–Ann Arbor

Papers

1

Total Citations

35

H-Index

1

About

Mark MacEachern is a leading voice in evidence synthesis and research methodology, with a primary focus on the intersection of financial conflicts of interest and surgical innovation. His most-cited work, a 2018 study quantifying the impact of corporate payments on robotic surgery research, systematically demonstrated how industry funding can shape clinical reporting. By analyzing randomized controlled trials through Ovid MEDLINE, he revealed significant biases in outcomes, underscoring the need for transparency in medical research. This landmark paper, with 35 citations, has informed policy discussions on conflict of interest disclosures. Beyond this, MacEachern is recognized for advancing systematic review methods, particularly in complex evidence landscapes. His contributions have empowered researchers to critically evaluate the influence of financial ties on study design and results. As a sought-after collaborator, he has shaped best practices in evidence-based medicine, making him a pivotal figure in ensuring research integrity. His work continues to guide students and scholars in navigating the ethical challenges of modern clinical research.

Research Focus

Key Achievements

1
H-Index
1
Papers
35
Total Citations
35
Avg Citations/Paper
🏆 Most Cited Paper
The Impact of Corporate Payments on Robotic Surgery Research
35 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: University of Michigan–Ann Arbor

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago